img

Global Antidiabetic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antidiabetic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
Antidiabetic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidiabetic Drug market is projected to reach US$ 87890 million in 2034, increasing from US$ 44610 million in 2022, with the CAGR of 10.0% during the period of 2024 to 2034. Demand from Type I Diabetes and Type II Diabetes are the major drivers for the industry.
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidiabetic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Segment by Type
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones

Segment by Application


Type I Diabetes
Type II Diabetes

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antidiabetic Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidiabetic Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidiabetic Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Antidiabetic Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidiabetic Drug introduction, etc. Antidiabetic Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antidiabetic Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Antidiabetic Drug Market Overview
1.1 Antidiabetic Drug Product Overview
1.2 Antidiabetic Drug Market Segment by Type
1.2.1 Alpha-Glucosidase Inhibitors
1.2.2 Biguanides, Sulphonylureas
1.2.3 Glp-1 Agonist
1.2.4 Meglitinides
1.2.5 Dpp-4 Inhibitors
1.2.6 Sglt–2
1.2.7 Thiazolodinediones
1.3 Global Antidiabetic Drug Market Size by Type
1.3.1 Global Antidiabetic Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Antidiabetic Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Antidiabetic Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antidiabetic Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Antidiabetic Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Antidiabetic Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Antidiabetic Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Antidiabetic Drug Sales Breakdown by Type (2024-2024)
2 Global Antidiabetic Drug Market Competition by Company
2.1 Global Top Players by Antidiabetic Drug Sales (2024-2024)
2.2 Global Top Players by Antidiabetic Drug Revenue (2024-2024)
2.3 Global Top Players by Antidiabetic Drug Price (2024-2024)
2.4 Global Top Manufacturers Antidiabetic Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetic Drug Market Competitive Situation and Trends
2.5.1 Antidiabetic Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antidiabetic Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Antidiabetic Drug Market
2.8 Key Manufacturers Antidiabetic Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antidiabetic Drug Status and Outlook by Region
3.1 Global Antidiabetic Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Antidiabetic Drug Historic Market Size by Region
3.2.1 Global Antidiabetic Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Antidiabetic Drug Sales in Value by Region (2024-2024)
3.2.3 Global Antidiabetic Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Antidiabetic Drug Forecasted Market Size by Region
3.3.1 Global Antidiabetic Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Antidiabetic Drug Sales in Value by Region (2024-2034)
3.3.3 Global Antidiabetic Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antidiabetic Drug by Application
4.1 Antidiabetic Drug Market Segment by Application
4.1.1 Type I Diabetes
4.1.2 Type II Diabetes
4.2 Global Antidiabetic Drug Market Size by Application
4.2.1 Global Antidiabetic Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Antidiabetic Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Antidiabetic Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antidiabetic Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Antidiabetic Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Antidiabetic Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Antidiabetic Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Antidiabetic Drug Sales Breakdown by Application (2024-2024)
5 North America Antidiabetic Drug by Country
5.1 North America Antidiabetic Drug Historic Market Size by Country
5.1.1 North America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Antidiabetic Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Antidiabetic Drug Sales in Value by Country (2024-2024)
5.2 North America Antidiabetic Drug Forecasted Market Size by Country
5.2.1 North America Antidiabetic Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Antidiabetic Drug Sales in Value by Country (2024-2034)
6 Europe Antidiabetic Drug by Country
6.1 Europe Antidiabetic Drug Historic Market Size by Country
6.1.1 Europe Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Antidiabetic Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Antidiabetic Drug Sales in Value by Country (2024-2024)
6.2 Europe Antidiabetic Drug Forecasted Market Size by Country
6.2.1 Europe Antidiabetic Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Antidiabetic Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Antidiabetic Drug by Region
7.1 Asia-Pacific Antidiabetic Drug Historic Market Size by Region
7.1.1 Asia-Pacific Antidiabetic Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Antidiabetic Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Antidiabetic Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Antidiabetic Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Antidiabetic Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antidiabetic Drug Sales in Value by Region (2024-2034)
8 Latin America Antidiabetic Drug by Country
8.1 Latin America Antidiabetic Drug Historic Market Size by Country
8.1.1 Latin America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Antidiabetic Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Antidiabetic Drug Sales in Value by Country (2024-2024)
8.2 Latin America Antidiabetic Drug Forecasted Market Size by Country
8.2.1 Latin America Antidiabetic Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antidiabetic Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Antidiabetic Drug by Country
9.1 Middle East and Africa Antidiabetic Drug Historic Market Size by Country
9.1.1 Middle East and Africa Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Antidiabetic Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Antidiabetic Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Antidiabetic Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Antidiabetic Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antidiabetic Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi-Aventis
10.1.1 Sanofi-Aventis Company Information
10.1.2 Sanofi-Aventis Introduction and Business Overview
10.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Sanofi-Aventis Antidiabetic Drug Products Offered
10.1.5 Sanofi-Aventis Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Eli Lilly Antidiabetic Drug Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Oramed
10.3.1 Oramed Company Information
10.3.2 Oramed Introduction and Business Overview
10.3.3 Oramed Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Oramed Antidiabetic Drug Products Offered
10.3.5 Oramed Recent Development
10.4 Takeda
10.4.1 Takeda Company Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Takeda Antidiabetic Drug Products Offered
10.4.5 Takeda Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Boehringer Ingelheim Antidiabetic Drug Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 Novo Nordisk
10.6.1 Novo Nordisk Company Information
10.6.2 Novo Nordisk Introduction and Business Overview
10.6.3 Novo Nordisk Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Novo Nordisk Antidiabetic Drug Products Offered
10.6.5 Novo Nordisk Recent Development
10.7 Halozyme Therapeutics
10.7.1 Halozyme Therapeutics Company Information
10.7.2 Halozyme Therapeutics Introduction and Business Overview
10.7.3 Halozyme Therapeutics Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Halozyme Therapeutics Antidiabetic Drug Products Offered
10.7.5 Halozyme Therapeutics Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Bristol-Myers Squibb Antidiabetic Drug Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Information
10.9.2 Pfizer Introduction and Business Overview
10.9.3 Pfizer Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Pfizer Antidiabetic Drug Products Offered
10.9.5 Pfizer Recent Development
10.10 Tonghua Dongbao
10.10.1 Tonghua Dongbao Company Information
10.10.2 Tonghua Dongbao Introduction and Business Overview
10.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Tonghua Dongbao Antidiabetic Drug Products Offered
10.10.5 Tonghua Dongbao Recent Development
10.11 Biocon
10.11.1 Biocon Company Information
10.11.2 Biocon Introduction and Business Overview
10.11.3 Biocon Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Biocon Antidiabetic Drug Products Offered
10.11.5 Biocon Recent Development
10.12 Wockhardt
10.12.1 Wockhardt Company Information
10.12.2 Wockhardt Introduction and Business Overview
10.12.3 Wockhardt Antidiabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Wockhardt Antidiabetic Drug Products Offered
10.12.5 Wockhardt Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antidiabetic Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antidiabetic Drug Industrial Chain Analysis
11.4 Antidiabetic Drug Market Dynamics
11.4.1 Antidiabetic Drug Industry Trends
11.4.2 Antidiabetic Drug Market Drivers
11.4.3 Antidiabetic Drug Market Challenges
11.4.4 Antidiabetic Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antidiabetic Drug Distributors
12.3 Antidiabetic Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Alpha-Glucosidase Inhibitors
Table 2. Major Company of Biguanides, Sulphonylureas
Table 3. Major Company of Glp-1 Agonist
Table 4. Major Company of Meglitinides
Table 5. Major Company of Dpp-4 Inhibitors
Table 6. Major Company of Sglt–2
Table 7. Major Company of Thiazolodinediones
Table 8. Global Antidiabetic Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global Antidiabetic Drug Sales by Type (2024-2024) & (K Units)
Table 10. Global Antidiabetic Drug Sales Market Share in Volume by Type (2024-2024)
Table 11. Global Antidiabetic Drug Sales by Type (2024-2024) & (US& Million)
Table 12. Global Antidiabetic Drug Market Share in Value by Type (2024-2024)
Table 13. Global Antidiabetic Drug Price by Type (2024-2024) & (USD/Unit)
Table 14. Global Antidiabetic Drug Sales by Type (2024-2034) & (K Units)
Table 15. Global Antidiabetic Drug Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Antidiabetic Drug Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Antidiabetic Drug Sales Market Share in Value by Type (2024-2034)
Table 18. Global Antidiabetic Drug Price by Type (2024-2034) & (USD/Unit)
Table 19. North America Antidiabetic Drug Sales by Type (2024-2024) & (K Units)
Table 20. North America Antidiabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 21. Europe Antidiabetic Drug Sales (K Units) by Type (2024-2024)
Table 22. Europe Antidiabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 23. Asia-Pacific Antidiabetic Drug Sales (K Units) by Type (2024-2024)
Table 24. Asia-Pacific Antidiabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 25. Latin America Antidiabetic Drug Sales (K Units) by Type (2024-2024)
Table 26. Latin America Antidiabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 27. Middle East and Africa Antidiabetic Drug Sales (K Units) by Type (2024-2024)
Table 28. Middle East and Africa Antidiabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 29. Global Antidiabetic Drug Sales by Company (2024-2024) & (K Units)
Table 30. Global Antidiabetic Drug Sales Share by Company (2024-2024)
Table 31. Global Antidiabetic Drug Revenue by Company (2024-2024) & (US$ Million)
Table 32. Global Antidiabetic Drug Revenue Share by Company (2024-2024)
Table 33. Global Market Antidiabetic Drug Price by Company (2024-2024) & (USD/Unit)
Table 34. Global Antidiabetic Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Antidiabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Drug as of 2022)
Table 37. Date of Key Manufacturers Enter into Antidiabetic Drug Market
Table 38. Key Manufacturers Antidiabetic Drug Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Antidiabetic Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Global Antidiabetic Drug Sales by Region (2024-2024) & (K Units)
Table 42. Global Antidiabetic Drug Sales Market Share in Volume by Region (2024-2024)
Table 43. Global Antidiabetic Drug Sales by Region (2024-2024) & (US$ Million)
Table 44. Global Antidiabetic Drug Sales Market Share in Value by Region (2024-2024)
Table 45. Global Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 46. Global Antidiabetic Drug Sales by Region (2024-2034) & (K Units)
Table 47. Global Antidiabetic Drug Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Antidiabetic Drug Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Antidiabetic Drug Sales Market Share in Value by Region (2024-2034)
Table 50. Global Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 51. Global Antidiabetic Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 52. Global Antidiabetic Drug Sales by Application (2024-2024) & (K Units)
Table 53. Global Antidiabetic Drug Sales Market Share in Volume by Application (2024-2024)
Table 54. Global Antidiabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 55. Global Antidiabetic Drug Sales Market Share in Value by Application (2024-2024)
Table 56. Global Antidiabetic Drug Price by Application (2024-2024) & (USD/Unit)
Table 57. Global Antidiabetic Drug Sales by Application (2024-2034) & (K Units)
Table 58. Global Antidiabetic Drug Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Antidiabetic Drug Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Antidiabetic Drug Sales Market Share in Value by Application (2024-2034)
Table 61. Global Antidiabetic Drug Price by Application (2024-2034) & (USD/Unit)
Table 62. North America Antidiabetic Drug Sales by Application (2024-2024) (K Units)
Table 63. North America Antidiabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 64. Europe Antidiabetic Drug Sales by Application (2024-2024) (K Units)
Table 65. Europe Antidiabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 66. Asia-Pacific Antidiabetic Drug Sales by Application (2024-2024) (K Units)
Table 67. Asia-Pacific Antidiabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 68. Latin America Antidiabetic Drug Sales by Application (2024-2024) (K Units)
Table 69. Latin America Antidiabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 70. Middle East and Africa Antidiabetic Drug Sales by Application (2024-2024) (K Units)
Table 71. Middle East and Africa Antidiabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 72. North America Antidiabetic Drug Sales by Country (2024-2024) & (K Units)
Table 73. North America Antidiabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 74. North America Antidiabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 75. North America Antidiabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 76. North America Antidiabetic Drug Sales by Country (2024-2034) & (K Units)
Table 77. North America Antidiabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Antidiabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Antidiabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Antidiabetic Drug Sales by Country (2024-2024) & (K Units)
Table 81. Europe Antidiabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 82. Europe Antidiabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 83. Europe Antidiabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 84. Europe Antidiabetic Drug Sales by Country (2024-2034) & (K Units)
Table 85. Europe Antidiabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Antidiabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Antidiabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Antidiabetic Drug Sales by Region (2024-2024) & (K Units)
Table 89. Asia-Pacific Antidiabetic Drug Sales Market Share in Volume by Region (2024-2024)
Table 90. Asia-Pacific Antidiabetic Drug Sales by Region (2024-2024) & (US$ Million)
Table 91. Asia-Pacific Antidiabetic Drug Sales Market Share in Value by Region (2024-2024)
Table 92. Asia-Pacific Antidiabetic Drug Sales by Region (2024-2034) & (K Units)
Table 93. Asia-Pacific Antidiabetic Drug Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Antidiabetic Drug Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Antidiabetic Drug Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Antidiabetic Drug Sales by Country (2024-2024) & (K Units)
Table 97. Latin America Antidiabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 98. Latin America Antidiabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 99. Latin America Antidiabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 100. Latin America Antidiabetic Drug Sales by Country (2024-2034) & (K Units)
Table 101. Latin America Antidiabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Antidiabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Antidiabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Antidiabetic Drug Sales by Country (2024-2024) & (K Units)
Table 105. Middle East and Africa Antidiabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 106. Middle East and Africa Antidiabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 107. Middle East and Africa Antidiabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 108. Middle East and Africa Antidiabetic Drug Sales by Country (2024-2034) & (K Units)
Table 109. Middle East and Africa Antidiabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Antidiabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Antidiabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 112. Sanofi-Aventis Company Information
Table 113. Sanofi-Aventis Introduction and Business Overview
Table 114. Sanofi-Aventis Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Sanofi-Aventis Antidiabetic Drug Product
Table 116. Sanofi-Aventis Recent Development
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Introduction and Business Overview
Table 119. Eli Lilly Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Eli Lilly Antidiabetic Drug Product
Table 121. Eli Lilly Recent Development
Table 122. Oramed Company Information
Table 123. Oramed Introduction and Business Overview
Table 124. Oramed Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Oramed Antidiabetic Drug Product
Table 126. Oramed Recent Development
Table 127. Takeda Company Information
Table 128. Takeda Introduction and Business Overview
Table 129. Takeda Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Takeda Antidiabetic Drug Product
Table 131. Takeda Recent Development
Table 132. Boehringer Ingelheim Company Information
Table 133. Boehringer Ingelheim Introduction and Business Overview
Table 134. Boehringer Ingelheim Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. Boehringer Ingelheim Antidiabetic Drug Product
Table 136. Boehringer Ingelheim Recent Development
Table 137. Novo Nordisk Company Information
Table 138. Novo Nordisk Introduction and Business Overview
Table 139. Novo Nordisk Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Novo Nordisk Antidiabetic Drug Product
Table 141. Novo Nordisk Recent Development
Table 142. Halozyme Therapeutics Company Information
Table 143. Halozyme Therapeutics Introduction and Business Overview
Table 144. Halozyme Therapeutics Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. Halozyme Therapeutics Antidiabetic Drug Product
Table 146. Halozyme Therapeutics Recent Development
Table 147. Bristol-Myers Squibb Company Information
Table 148. Bristol-Myers Squibb Introduction and Business Overview
Table 149. Bristol-Myers Squibb Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. Bristol-Myers Squibb Antidiabetic Drug Product
Table 151. Bristol-Myers Squibb Recent Development
Table 152. Pfizer Company Information
Table 153. Pfizer Introduction and Business Overview
Table 154. Pfizer Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 155. Pfizer Antidiabetic Drug Product
Table 156. Pfizer Recent Development
Table 157. Tonghua Dongbao Company Information
Table 158. Tonghua Dongbao Introduction and Business Overview
Table 159. Tonghua Dongbao Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 160. Tonghua Dongbao Antidiabetic Drug Product
Table 161. Tonghua Dongbao Recent Development
Table 162. Biocon Company Information
Table 163. Biocon Introduction and Business Overview
Table 164. Biocon Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 165. Biocon Antidiabetic Drug Product
Table 166. Biocon Recent Development
Table 167. Wockhardt Company Information
Table 168. Wockhardt Introduction and Business Overview
Table 169. Wockhardt Antidiabetic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 170. Wockhardt Antidiabetic Drug Product
Table 171. Wockhardt Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Antidiabetic Drug Market Trends
Table 175. Antidiabetic Drug Market Drivers
Table 176. Antidiabetic Drug Market Challenges
Table 177. Antidiabetic Drug Market Restraints
Table 178. Antidiabetic Drug Distributors List
Table 179. Antidiabetic Drug Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetic Drug Product Picture
Figure 2. Global Antidiabetic Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antidiabetic Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Antidiabetic Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Alpha-Glucosidase Inhibitors
Figure 6. Global Alpha-Glucosidase Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Biguanides, Sulphonylureas
Figure 8. Global Biguanides, Sulphonylureas Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Glp-1 Agonist
Figure 10. Global Glp-1 Agonist Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Meglitinides
Figure 12. Global Meglitinides Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Dpp-4 Inhibitors
Figure 14. Global Dpp-4 Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Sglt–2
Figure 16. Global Sglt–2 Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Product Picture of Thiazolodinediones
Figure 18. Global Thiazolodinediones Sales YoY Growth (2024-2034) & (K Units)
Figure 19. Global Antidiabetic Drug Sales by Type (2024-2034) & (US$ Million)
Figure 20. Global Antidiabetic Drug Sales Market Share by Type in 2022 & 2034
Figure 21. North America Antidiabetic Drug Sales Market Share in Volume by Type in 2022
Figure 22. North America Antidiabetic Drug Sales Market Share in Value by Type in 2022
Figure 23. Europe Antidiabetic Drug Sales Market Share in Volume by Type in 2022
Figure 24. Europe Antidiabetic Drug Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Antidiabetic Drug Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Antidiabetic Drug Sales Market Share in Value by Type in 2022
Figure 27. Latin America Antidiabetic Drug Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Antidiabetic Drug Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Antidiabetic Drug Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Antidiabetic Drug Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Drug Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Drug Revenue in 2022
Figure 33. Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Product Picture of Type I Diabetes
Figure 35. Global Type I Diabetes Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Type II Diabetes
Figure 37. Global Type II Diabetes Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Antidiabetic Drug Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Antidiabetic Drug Sales Market Share by Application in 2022 & 2034
Figure 40. North America Antidiabetic Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America Antidiabetic Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe Antidiabetic Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe Antidiabetic Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Antidiabetic Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Antidiabetic Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America Antidiabetic Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Antidiabetic Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Antidiabetic Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Antidiabetic Drug Manufacturing Cost Structure
Figure 51. Antidiabetic Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries